by APFLI | Mar 12, 2005 | Contraception - Chemical Methods / Hormonal Contraception / Emergency / Morning After Pill
Doctors at the Mount Sinai School of Medicine have tested a gel that when applied topically in the vagina, may help prevent infection by both H.I.V. and herpes simplex virus. AIDS researchers have long sought such a microbicide. The effectiveness of the gel, called...
by APFLI | Feb 27, 2005 | STDs, STIs, HIV - Archive
A group of physicians has presented to Canadian Parliamentarians scientific evidence that homosexual marriage is a health risk to Canadians. The heavily referenced brief titled “Gay Marriage and Homosexuality, Some Medical Comments” warns that the new law...
by APFLI | Jan 28, 2005 | Barrier Methods
During the XIII International AIDS Conference held in Durban, South Africa, July 2000, researchers from the Joint United Nations Program on AIDS (UNAIDS) presented results of a study of a product, COL-1492,* which contains nonoxynol-9 (N-9) (1). N-9 products are...
by APFLI | Jan 5, 2005 | STDs, STIs, HIV - Archive
DIAGNOSES OF HIV/AIDS — 32 States, 2000-2003 – An estimated 850,000–950,000 persons in the USA are living with human immunodeficiency virus (HIV), including 180,000–280,000 who do not know they are infected During 2000-2003, HIV/AIDS was...
by APFLI | Jan 1, 2005 | STDs, STIs, HIV - Archive
“An experimental drug in the form of a vaginal gel is being tested on female monkeys to prevent the HIV virus from gaining access to the body. The drug works by preventing the virus from penetrating a woman’s cells. “In many parts of the world, the...
